Interdiscipinary Leukemia Project Launches "What's New in t-AML"
This page features significant recent studies in therapy-related Acute Myeloid Leukemia. Studies are organized into three main sections: t-AML diagnosis and incidence, genetic abnormalities in t-AML, and t-AML treatment and outcomes. Where possible, links to the primary publications are included. The page can be found at https://t-aml.uchicago.edu/resources-publications/whats-new-in-t-aml/
The Interdisciplinary Leukemia Project is a six-part systems biology-based interdisciplinary attack on therapy-based Acute Myeloid Leukemia, a secondary cancer that strikes 8 to 10% of cancer survivors. The five year program includes high-throughput genomic screening, work in blood stem cells, clinical trials and high-level informatics, all focused on the same disease and pursued at the same time in a coordinated manner. While the primary goal of this project is to find answers surrounding this terrible disease, the hope is that by applying a systems-based approach to cancer research, the project will be able to change the way that cancer science is pursued.
"I owe a great deal to the Cancer Research Foundation for giving me a head start. This financial help made the difference between my getting a fast and successful start, and my other wise struggling to obtain the necessary funds to get my research program started."Elaine Fuchs, Ph.D.
Professor, Departments of Medicine and Molecular Genetics and Cell Biology and Human Genetics University of Chicago
April 30, 2010